The Biocomplex Assembled from Antigen Peptide and Toll-like Receptor Agonist Improved the Immunity against Pancreatic Adenocarcinoma In Vivo

PURPOSE: One of the biggest challenges in cancer immunotherapy is generating robust cancer-specific immunity. This work describes using a biocomplex assembled from a toll-like receptor agonist CpG oligodeoxynucleotide 1826 (CpG) and a pancreatic cancer antigen peptide mesothelin for tuning pancreati...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wenming, Yu, Hongbin, Xue, Tao, Wu, Chunyong, Ren, Fan, Cui, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436581/
https://www.ncbi.nlm.nih.gov/pubmed/36059807
http://dx.doi.org/10.1155/2022/2965496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436581/
https://www.ncbi.nlm.nih.gov/pubmed/36059807
http://dx.doi.org/10.1155/2022/2965496

Ejemplares similares